|
1.
|
|
34 p, 677.3 KB |
Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) in Latin-American migrants in Barcelona (Spain)
/
Abras, Alba (Universitat de Girona. Departament de Biologia) ;
Gállego Culleré, M. (Montserrat) (Institut de Salut Global de Barcelona) ;
Muñoz-Batet, Carmen (Institut d'Investigació Biomèdica Sant Pau) ;
Juiz, Natalia A. (Laboratorio de Biología Molecular de la Enfermedad de Chagas) ;
Ramírez, Juan Carlos (Laboratorio de Biología Molecular de la Enfermedad de Chagas) ;
Cura, Carolina I. (Laboratorio de Biología Molecular de la Enfermedad de Chagas) ;
Tebar, Silvia (Universitat de Barcelona. Departament de Biologia, Sanitat i Medi Ambient) ;
Fernández-Arévalo, Anna (Institut d'Investigació Biomèdica Sant Pau) ;
Pinazo, María-Jesus (Institut de Salut Global de Barcelona) ;
de la Torre, Leonardo (Institut de Salut Global de Barcelona) ;
Posada, Elizabeth (Institut de Salut Global de Barcelona) ;
Navarro Risueño, Ferran (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Espinal, Paula (Institut d'Investigació Biomèdica Sant Pau) ;
Ballart, Cristina (Institut de Salut Global de Barcelona) ;
Portús, Montserrat (Universitat de Barcelona. Departament de Biologia, Sanitat i Medi Ambient) ;
Gascon, Joaquim (Institut de Salut Global de Barcelona) ;
Schijman, Alejandro G. (Laboratorio de Biología Molecular de la Enfermedad de Chagas)
Trypanosoma cruzi, the causative agent of Chagas disease, is divided into six Discrete Typing Units (DTUs): TcI-TcVI. We aimed to identify T. cruzi DTUs in Latin-American migrants in the Barcelona area (Spain) and to assess different molecular typing approaches for the characterization of T. [...]
2017 -  10.1016/j.parint.2016.12.003
Parasitology International, Vol. 66, Issue 2 (April 2017) , p. 83-88
|
|
|
2.
|
|
8 p, 1.2 MB |
Opportunistic Community Screening of Chronic Chagas Disease Using a Rapid Diagnosis Test in Pharmacies in Barcelona (Catalonia, Spain) : Study Protocol and Pilot Phase Results
/
Silgado, Aroa (Hospital Universitari Vall d'Hebron) ;
Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron) ;
Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ;
Cervià, Ariadna (Col·legi de Farmacèutics de Barcelona) ;
Gómez i Prat, Jordi (Hospital Universitari Vall d'Hebron) ;
Bagaria, Guillermo (Col·legi de Farmacèutics de Barcelona) ;
Rodríguez, Cristina (Col·legi de Farmacèutics de Barcelona) ;
Goterris, Lidia (Hospital Universitari Vall d'Hebron) ;
Serre-Delcor, Núria (Hospital Universitari Vall d'Hebron) ;
Oliveira-Souto, Inés (Hospital Universitari Vall d'Hebron) ;
Salvador, Fernando (Hospital Universitari Vall d'Hebron) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron) ;
Sulleiro Igual, Elena (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
This study aimed to report the protocol and results from the pilot phase of an opportunistic CP-based CD screening program in Barcelona, Spain. Three strategies according to recruitment approach were designed: passive, active and active-community. [...]
2022 - 10.3389/ijph.2022.1605386
International Journal of Public Health, Vol. 67 (november 2022)
|
|
|
3.
|
|
15 p, 2.5 MB |
Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic : Trends by Different Molecular Approaches
/
Flores-Chavez, Maria (Fundación Mundo Sano-España) ;
Abras, Alba (Universitat de Girona. Departament de Biologia) ;
Ballart, Cristina (Universitat de Barcelona. Secció de Parasitologia. Departament de Biologia Sanitat i Medi Ambient. Facultat de Farmàcia i Ciències de l'Alimentació) ;
Ibáñez-Perez, Ismael (National Centre for Microbiology. Instituto de Salud Carlos III) ;
Perez-Gordillo, Pilar (National Centre for Microbiology. Instituto de Salud Carlos III) ;
Gállego Culleré, M. (Montserrat) (Centro de Investigación Biomédica en Red de Enfermedades Infecciosas) ;
Muñoz-Batet, Carmen (Institut d'Investigació Biomèdica Sant Pau) ;
Moure García, Zaira (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Sulleiro Igual, Elena (Hospital Universitari Vall d'Hebron) ;
Nieto, Javier (Centro de Investigación Biomédica en Red de Enfermedades Infecciosas) ;
García Diez, Emilia (National Centre for Microbiology. Instituto de Salud Carlos III) ;
Simón, Lorena (National Centre of Epidemiology. Instituto de Salud Carlos III) ;
Cruz, Israel (Foundation for Innovative New Diagnostics (FIND)) ;
Picado, Alberto (Foundation for Innovative New Diagnostics (FIND)) ;
Universitat Autònoma de Barcelona
Trypanosoma cruzi infection has expanded globally through human migration. In Spain, the mother-to-child route is the mode of transmission contributing to autochthonous Chagas disease (CD); however, most people acquired the infection in their country of origin and were diagnosed in the chronic phase (imported chronic CD). [...]
2022 - 10.1128/spectrum.02628-22
Microbiology Spectrum, Vol. 10 Núm. 5 (september 2022)
|
|
|
4.
|
|
10 p, 1.3 MB |
Benznidazole Treatment : Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain
/
Fonseca, Kátia da Silva (Federal University of Ouro Preto) ;
Perin, Luísa (University of Ouro Preto) ;
de Paiva, Nívia Carolina Nogueira (Federal University of Ouro Preto) ;
da Silva, Beatriz Cristiane (Federal University of Ouro Preto) ;
Duarte, Thays Helena Chaves (Federal University of Ouro Pretotment of Biological Sciences, Nucleus of Biological Sciences Research) ;
Marques, Flávia de Souza (Federal University of Ouro Preto) ;
Costa, Guilherme de Paula (Federal University of Ouro Preto) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Correa-Oliveira, Rodrigo (Fundação Oswaldo Cruz (Brasil)) ;
Vieira, Paula Melo de Abreu (Federal University of Ouro Preto) ;
Carneiro, Cláudia Martins (Federal University of Ouro Preto) ;
Universitat Autònoma de Barcelona
As the development of new drugs for Chagas disease is not a priority due to its neglected disease status, an option for increasing treatment adherence is to explore alternative treatment regimens, which may decrease the incidence of side effects. [...]
2021 - 10.3390/pathogens10060729
Pathogens, Vol. 10 (june 2021)
|
|
|
5.
|
|
|
6.
|
|
9 p, 1.2 MB |
Intra-Discrete Typing Unit TcV Genetic Variability of Trypanosoma cruzi in Chronic Chagas' Disease Bolivian Immigrant Patients in Barcelona, Spain
/
de Oliveira, Maykon Tavares (University of São Paulo) ;
Sulleiro Igual, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
da Silva, Maria Cláudia (University of São Paulo) ;
Silgado, Aroa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Lana, Marta (Federal University of Ouro Preto) ;
da Silva, João Santana (Fiocruz-Bi-Institutional Translational Medicine Plataform) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Marin-Neto, J. Antônio (University of São Paulo) ;
Universitat Autònoma de Barcelona
Background: Trypanosoma cruzi has a high rate of biological and genetic variability, and its population structure is divided into seven distinct genetic groups (TcI-TcVI and Tcbat). Due to immigration, Chagas disease (ChD), caused by T. [...]
2021 - 10.3389/fcvm.2021.665624
Frontiers in Cardiovascular Medicine, Vol. 8 (may 2021)
|
|
|
7.
|
|
10 p, 658.6 KB |
Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study) : study protocol for a multicenter randomized Phase II non-inferiority clinical trial
/
Molina-Morant, D. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Fernández, M. L. (Ministerio de Salud y Desarrollo Social) ;
Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sulleiro Igual, Elena (Hospital Universitari Vall d'Hebron) ;
Bangher, M. (Instituto de Cardiología de Corrientes Juana Francisca Cabral (Argentina)) ;
Salvador, F. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sanchez-Montalva, A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ribeiro, A. L. P. (Faculdade de Medicina da Universidade Federal de Minas Gerais) ;
de Paula, A. M. B. (Universidade Estadual de Montes Claros) ;
Eloi, S. (Faculdade de Medicina da Universidade José do Rosário Vellano) ;
Correa-Oliveira, Rodrigo (René Rachou Institute) ;
Villar, J. C. (Universidad Autónoma de Bucaramanga) ;
Sosa-Estani, S. (Epidemiology and Public Health Research Center, CONICET) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Chagas disease (CD) continues to be a neglected infectious disease with one of the largest burdens globally. Despite the modest cure rates in adult chronic patients and its safety profile, benznidazole (BNZ) is still the drug of choice. [...]
2020 - 10.1186/s13063-020-4226-2
Trials, Vol. 21 (april 2020)
|
|
|
8.
|
|
12 p, 734.6 KB |
Evaluation of the Performance of the Loopamp Detection Kit for the Diagnosis of Chagas Disease in an Area Where It Is Not Endemic, Spain
/
Flores-Chavez, Maria (Instituto de Salud Carlos III) ;
Abras, Alba (Universitat de Barcelona) ;
Ballart, Cristina (Universitat de Barcelona) ;
Ibáñez Perez, Ismael (Instituto de Salud Carlos III) ;
Perez-Gordillo, Pilar (Instituto de Salud Carlos III) ;
Gállego Culleré, M. (Montserrat) (Universitat de Barcelona) ;
Muñoz, Carmen (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Moure García, Zaira (Hospital Universitari Vall d'Hebron) ;
Sulleiro Igual, Elena (Hospital Universitari Vall d'Hebron) ;
Nieto, Javier (Instituto de Salud Carlos III) ;
García Diez, Emilia (Instituto de Salud Carlos III) ;
Cruz, Israel (Foundation for Innovative New Diagnostics FIND) ;
Picado, Albert (Foundation for Innovative New Diagnostics FIND)
In Spain, PCR is the tool of choice for the diagnosis of congenital Chagas disease (CD) and serology for diagnosing chronic CD. A loop-mediated isothermal amplification test for DNA detection showed good analytical performance and ease of use. [...]
2021 - 10.1128/JCM.01860-20
Journal of Clinical Microbiology, Vol. 59, Issue 5 (May 2021) , art. e01860-20
|
|
|
9.
|
|
16 p, 2.8 MB |
Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds
/
Martinez-Peinado, Nieves (Institut de Salut Global de Barcelona) ;
Cortés Serra, Núria (Institut de Salut Global de Barcelona) ;
Sherman, Julian (New York University School of Medicine. Department of Microbiology) ;
Rodriguez, Ana (New York University School of Medicine. Department of Microbiology) ;
Gascon, Joaquim (Barcelona Institute for Global Health (ISGlobal)) ;
Alberola, Jordi (Alberola i Domingo) (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Pinazo, Maria-Jesus (Institut de Salut Global de Barcelona) ;
Rodríguez-Cortés, Alhelí (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Alonso-Padilla, Julio (Institut de Salut Global de Barcelona) ;
Martori Muntsant, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects over 6 million people worldwide. Development of new drugs to treat this disease remains a priority since those currently available have variable efficacy and frequent adverse effects, especially during the long regimens required for treating the chronic stage of the disease. [...]
2021 - 10.3390/ijms22020688
International journal of molecular sciences, Vol. 22 Núm. 2 (2021) , p. 688
|
|
|
10.
|
|
13 p, 335.7 KB |
Screening for Trypanosoma cruzi infection in immigrants and refugees : Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology
/
Velasco, María (Hospital Universitario Fundación Alcorcón) ;
Gimeno-Feliu, Luis Andrés (Health Services Research on Chronic Patients Network (REDISSEC), Instituto de Salud Carlos III, Madrid, Spain) ;
Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Salas-Coronas, Joaquín (Tropical Medicine Unit. Hospital de Poniente, El Ejido, Almería, Spain) ;
Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ;
Monge-Maillo, Begoña (National Referral Centre for Tropical Diseases, Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain) ;
Torrús-Tendero, Diego (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Caylà, Joan A.. (Fundació de la Unitat d'Investigació en Tuberculosi de Barcelona) ;
de Guzmán, Ena Niño (Institut d'Investigació Biomèdica Sant Pau) ;
Arellano, J. L. Pérez (Universidad de Las Palmas de Gran Canaria. Departamento de Ciencias Médicas y Quirúrgicas) ;
Pérez-Molina, Jose A. (National Referral Centre for Tropical Diseases, Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain) ;
Universitat Autònoma de Barcelona
Chagas disease has spread beyond its original borders on the American continent with migration. It can be transmitted from mother to child, through organ transplantation and transfusion of blood and blood products. [...]
2020 - 10.2807/1560-7917.ES.2020.25.8.1900393
Eurosurveillance, Vol. 25 (february 2020)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
